Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Selcuk, Z.
Right arrow Articles by Baris, Y.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Selcuk, Z.
Right arrow Articles by Baris, Y.

Chest, Vol 102, 790-796, Copyright © 1992 by American College of Chest Physicians

ARTICLES

Malignant pleural mesothelioma due to environmental mineral fiber exposure in Turkey. Analysis of 135 cases

ZT Selcuk, L Coplu, S Emri, AF Kalyoncu, AA Sahin and YI Baris
Department of Chest Diseases, Hacettepe University School of Medicine, Ankara, Turkey.

We reviewed data from 135 patients with environment-associated malignant pleural mesothelioma (MPM) from the Central Anatolian region of Turkey. The most significant factors suggesting the diagnosis of MPM were the village where the patient resided and the typical presenting symptoms and signs of unilateral exudative pleural effusion associated with nonpleuritic chest pain. Computed tomography and ultrasonography were very useful for evaluating the extension of the tumor in the thoracic and abdominal cavities and chest wall. The tissue diagnosis was established by either thoracoscopy (39 percent) or pleural biopsy (39 percent) in the majority of the cases. The median survival after diagnosis was 13.52 months for erionite-associated MPM and 21.56 months for asbestos-associated MPM. The actuarial survival curves for the fibrous minerals were significantly different for survival computed both from onset of the symptoms and after diagnosis. Medical or surgical treatment or both did not change the outcome of the disease.


This article has been cited by other articles:


Home page
 Eur Respir JHome page
M. Metintas, S. Metintas, G. Hillerdal, I. Ucgun, S. Erginel, F. Alatas, and H. Yildirim
Nonmalignant pleural lesions due to environmental exposure to asbestos: a field-based, cross-sectional study
Eur. Respir. J., November 1, 2005; 26(5): 875 - 880.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
S. Metintas, M. Metintas, I. Ucgun, and U. Oner
Malignant Mesothelioma due to Environmental Exposure to Asbestos: Follow-Up of a Turkish Cohort Living in a Rural Area
Chest, December 1, 2002; 122(6): 2224 - 2229.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. Dumortier, A. Gocmen, K. Laurent, A. Manco, and P. De Vuyst
The role of environmental and occupational exposures in Turkish immigrants with fibre-related disease
Eur. Respir. J., May 1, 2001; 17(5): 922 - 927.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. Metintas, N. Ozdemir, I. Ucgun, O. Elbek, M. Kolsuz, S. Mutlu, and S. Metintas
Cisplatin, Mitomycin, and Interferon-{alpha}2a Combination Chemoimmunotherapy in the Treatment of Diffuse Malignant Pleural Mesothelioma
Chest, August 1, 1999; 116(2): 391 - 398.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. DUMORTIER, L. COPLU, V. de MAERTELAER, S. EMRI, I. BARIS, and P. DE VUYST
Assessment of Environmental Asbestos Exposure in Turkey by Bronchoalveolar Lavage
Am. J. Respir. Crit. Care Med., December 1, 1998; 158(6): 1815 - 1824.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American College of Chest Physicians.